CN107629873B - A kind of method of low-temperature crystallization enriching fish oil EPA, DHA - Google Patents
A kind of method of low-temperature crystallization enriching fish oil EPA, DHA Download PDFInfo
- Publication number
- CN107629873B CN107629873B CN201710747330.0A CN201710747330A CN107629873B CN 107629873 B CN107629873 B CN 107629873B CN 201710747330 A CN201710747330 A CN 201710747330A CN 107629873 B CN107629873 B CN 107629873B
- Authority
- CN
- China
- Prior art keywords
- fish oil
- crystallization
- dha
- epa
- low
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000021323 fish oil Nutrition 0.000 title claims abstract description 138
- 238000002425 crystallisation Methods 0.000 title claims abstract description 136
- 230000008025 crystallization Effects 0.000 title claims abstract description 129
- 238000000034 method Methods 0.000 title claims abstract description 50
- 239000003960 organic solvent Substances 0.000 claims abstract description 63
- 239000013078 crystal Substances 0.000 claims abstract description 56
- 239000007788 liquid Substances 0.000 claims abstract description 46
- 238000003828 vacuum filtration Methods 0.000 claims abstract description 16
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 15
- 238000002156 mixing Methods 0.000 claims abstract 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 48
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 24
- 125000004494 ethyl ester group Chemical group 0.000 claims description 23
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- 239000004927 clay Substances 0.000 claims description 16
- 238000001816 cooling Methods 0.000 claims description 10
- 239000012046 mixed solvent Substances 0.000 claims description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 8
- 229960000935 dehydrated alcohol Drugs 0.000 claims 1
- 238000009413 insulation Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 238000012545 processing Methods 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 5
- 238000006243 chemical reaction Methods 0.000 abstract description 2
- 238000006317 isomerization reaction Methods 0.000 abstract description 2
- 230000002776 aggregation Effects 0.000 abstract 1
- 238000004220 aggregation Methods 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 44
- 238000000199 molecular distillation Methods 0.000 description 16
- 238000012360 testing method Methods 0.000 description 15
- 230000008569 process Effects 0.000 description 14
- 238000000926 separation method Methods 0.000 description 13
- 150000004671 saturated fatty acids Chemical class 0.000 description 11
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
- 235000003441 saturated fatty acids Nutrition 0.000 description 7
- 239000005909 Kieselgur Substances 0.000 description 6
- 238000007792 addition Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000004202 carbamide Substances 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 238000005265 energy consumption Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 230000006911 nucleation Effects 0.000 description 4
- 238000010899 nucleation Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000005189 flocculation Methods 0.000 description 2
- 230000016615 flocculation Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005297 material degradation process Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000012476 oxidizable substance Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Fats And Perfumes (AREA)
Abstract
Description
技术领域technical field
本发明属于水产品加工及保健品技术领域,涉及一种低温结晶富集鱼油EPA、DHA的方法。The invention belongs to the technical field of aquatic product processing and health care products, and relates to a method for enriching fish oil EPA and DHA by low-temperature crystallization.
背景技术Background technique
如今,中国已经成长为全球第三大EPA和DHA油市场,DHA+EPA已经取得新资源食品认证,且即将纳入DRI,将有利于进一步提高消费者的认知度。随着我国消费者收入、受教育程度以及健康意识逐年提高,对EPA、DHA预防动脉粥样硬化和心血管疾病、防癌抗癌、改善大脑机能、提高记忆力、促进婴幼儿智力发育等生理功能有了普遍的认识,尤其是近几年我国老龄化人口的增加,势必将给EPA和DHA产品带来新的市场机遇。Today, China has grown into the third largest EPA and DHA oil market in the world. DHA+EPA has obtained the new resource food certification and is about to be included in the DRI, which will help further improve consumer awareness. With the increasing income, education level and health awareness of consumers in my country year by year, EPA and DHA are more sensitive to physiological functions such as preventing atherosclerosis and cardiovascular diseases, preventing and fighting cancer, improving brain function, improving memory, and promoting the intellectual development of infants and young children. With the general understanding, especially the increase of aging population in my country in recent years, it is bound to bring new market opportunities to EPA and DHA products.
EPA和DHA属于n-3系列多不饱和脂肪酸,对人体具有重要的保健作用,鱼油因富含n-3系列多不饱和脂肪酸尤其是EPA和DHA多年来一直是国内外研究的热点之一。EPA and DHA belong to the n-3 series of polyunsaturated fatty acids, which have important health care effects on the human body. Fish oil has been one of the hot spots of research at home and abroad for many years because it is rich in n-3 series of polyunsaturated fatty acids, especially EPA and DHA.
目前,分离富集鱼油中多不饱和脂肪酸的方法主要有低温溶剂结晶法、尿素包合、超临界CO2萃取、分子蒸馏、酶浓缩法等。其中,低温结晶法具有操作简便,对仪器设备的要求低,且在低温环境下能够较好的保持不饱和脂肪酸的天然活性,分离效果较好等优点。袁晓艳等将混合脂肪酸以1:3(酸∶溶剂)溶解在石油醚中,冷却至5~7℃,结晶出饱和脂肪酸,再经抽滤、蒸馏得到不饱和脂肪酸,产率可达80%,可见低温结晶法具有一定的富集效果(袁晓艳,等.亚麻油中分离不饱和脂肪酸方法的研究[J].辽宁科技学院学报,2005,7(4):12-13)。At present, the methods for separating and enriching polyunsaturated fatty acids in fish oil mainly include low-temperature solvent crystallization method, urea inclusion, supercritical CO2 extraction, molecular distillation, enzyme concentration method, etc. Among them, the low-temperature crystallization method has the advantages of simple operation, low requirements for instruments and equipment, and can better maintain the natural activity of unsaturated fatty acids in a low-temperature environment, and has a better separation effect. Yuan Xiaoyan et al. dissolved the mixed fatty acid in petroleum ether at 1:3 (acid:solvent), cooled it to 5-7°C, crystallized the saturated fatty acid, and then filtered and distilled to obtain the unsaturated fatty acid, and the yield could reach 80%. It can be seen that the low temperature crystallization method has a certain enrichment effect (Yuan Xiaoyan, et al. Research on the separation of unsaturated fatty acids from linseed oil [J]. Journal of Liaoning Institute of Science and Technology, 2005, 7(4): 12-13).
到目前为止,关于富集鱼油多不饱和脂肪酸的报道很多,工业化生产乙酯化鱼油绝大多采用尿素包合与分子蒸馏联合的方法,几十年来没有突破。尿素包合法具有设备简单,条件温和,成本低,能比较完全的保留有效成分生理活性等优点,但是需耗费大量溶剂,存在溶剂回收和环境污染问题,不能将EPA和DHA分离。为提高产率,一般采用多次尿素包合法或与分子蒸馏技术结合使用。分子蒸馏技术分离纯化工艺相对繁琐,比如需要多级纯化,如何实现连续进料,固体进料高温加热时对物料降解的影响等。超临界萃取技术具有低温、高压、隔绝空气的特点,特别适用于热敏物质和易氧化物质的分离,它可以充分保护鱼油的品质不受破坏,产品品质较好,但此方法对设备要求高,能耗大,So far, there are many reports on the enrichment of polyunsaturated fatty acids in fish oil. Most of the industrial production of ethyl esterified fish oil adopts the combination of urea inclusion and molecular distillation, and there has been no breakthrough for decades. The urea inclusion method has the advantages of simple equipment, mild conditions, low cost, and complete retention of the physiological activity of the active ingredients. In order to improve the yield, multiple urea inclusion methods are generally used or combined with molecular distillation technology. The separation and purification process of molecular distillation technology is relatively cumbersome, such as the need for multi-stage purification, how to realize continuous feeding, and the influence of solid feed on material degradation when heated at high temperature. Supercritical extraction technology has the characteristics of low temperature, high pressure and air isolation, and is especially suitable for the separation of heat-sensitive substances and easily oxidizable substances. It can fully protect the quality of fish oil from damage, and the product quality is good, but this method requires high equipment. , the energy consumption is large,
而关于低温结晶法富集鱼油EPA/DHA的具体工艺研究未见报道,更难以找到相关条件参数作为参考,因此探索更多的富集方法,寻求更多的可能性,对于未来鱼油行业的升级改革十分重要。However, there is no report on the specific process research on the enrichment of EPA/DHA in fish oil by low temperature crystallization, and it is more difficult to find relevant condition parameters as a reference. Therefore, more enrichment methods are explored and more possibilities are sought for the future upgrade of the fish oil industry. Reform is very important.
发明内容SUMMARY OF THE INVENTION
本发明的目的是针对现有技术存在的上述问题,提出了一种低温结晶富集鱼油EPA、DHA的方法,设备简单,操作简便,单次处理量大,成本低,有效成分不易发生氧化、异构化、聚和等反应,能够较好的保持EPA、DHA的天然活性。The object of the present invention is to address the above-mentioned problems existing in the prior art, and propose a method for enriching EPA and DHA of fish oil by low-temperature crystallization, which has simple equipment, simple and convenient operation, large single treatment capacity, low cost, and the active ingredients are not easily oxidized. Isomerization, polymerization and other reactions can better maintain the natural activity of EPA and DHA.
本发明的目的可通过下列技术方案来实现:一种低温结晶富集鱼油EPA、DHA的方法,所述方法包括如下步骤:The object of the present invention can be realized by the following technical solutions: a method for enriching fish oil EPA, DHA by low-temperature crystallization, the method comprises the steps:
对鱼油进行预处理,然后在鱼油中加入有机溶剂和助晶剂,所述鱼油、有机溶剂和助晶剂的质量比为100:(200~1000):(0.5~2),混匀后进行低温结晶,真空抽滤分离结晶体和未结晶液体,然后除去未结晶液体中的有机溶剂和助晶剂,即得富集后的鱼油EPA、DHA。The fish oil is pretreated, and then an organic solvent and a crystallizing agent are added to the fish oil. Crystallization at low temperature, vacuum filtration to separate crystals and uncrystallized liquid, and then remove organic solvent and crystallizer in uncrystallized liquid to obtain enriched fish oil EPA and DHA.
本发明通过低温结晶法对鱼油中的EPA、DHA进行富集,操作简便,对仪器设备的要求低,单次处理量大,分离效果较好,且在低温环境下能够较好的保持EPA、DHA的天然活性。在低温结晶过程中,有机溶剂的加入提高了液相比例和结晶体的自由度,使得后期从未结晶液体中过滤分离结晶体容易进行。助晶剂的加入促进了结晶的进行,减小了结晶需要的过冷度,提高了结晶温度,减少了结晶时间。有机溶剂的用量与原料油中饱和脂肪酸的含量有关,用量过少,就不能全部结晶析出,用量过多,则可能导致原料油过分稀释影响结晶体的粒度和分布,使形成的结晶体粒度过小,过小的晶粒会吸附较多的EPA、DHA,降低分离效率,同时还造成溶剂的浪费,因此将鱼油与有机溶剂的比例限定在上述范围内。冷冻形成的饱和脂肪酸结晶结构强度有限,真空抽滤分离结晶体和未结晶液体可尽量避免絮流剪切,减少对结晶体的破坏。The invention enriches EPA and DHA in fish oil by a low-temperature crystallization method, which is easy to operate, has low requirements for instruments and equipment, has large single processing capacity, good separation effect, and can better maintain EPA and DHA in a low-temperature environment. Natural activity of DHA. In the low-temperature crystallization process, the addition of organic solvent increases the liquid phase ratio and the degree of freedom of crystals, making it easier to filter and separate crystals from the uncrystallized liquid in the later stage. The addition of the crystallizing agent promotes the crystallization, reduces the degree of undercooling required for the crystallization, increases the crystallization temperature, and reduces the crystallization time. The amount of organic solvent is related to the content of saturated fatty acid in the raw oil. If the amount is too small, all crystallization cannot be precipitated. If the amount is too large, it may lead to excessive dilution of the raw material oil, which may affect the particle size and distribution of the crystals, so that the particle size of the formed crystals is too small. Too small grains will adsorb more EPA and DHA, reduce the separation efficiency, and also cause waste of solvent. Therefore, the ratio of fish oil to organic solvent is limited to the above range. The crystal structure of saturated fatty acid formed by freezing is limited, and the separation of crystals and uncrystallized liquids by vacuum filtration can avoid flocculation shearing as much as possible and reduce the damage to crystals.
作为优选,所述鱼油为乙酯型鱼油。Preferably, the fish oil is ethyl ester type fish oil.
作为优选,乙酯化鱼油中的EPA、DHA质量百分比含量为50~70%。Preferably, the mass percentage content of EPA and DHA in the ethyl esterified fish oil is 50-70%.
作为优选,所述预处理为将鱼油在30~50℃下加热5~30min。Preferably, the pretreatment is to heat the fish oil at 30-50° C. for 5-30 min.
在鱼油的加工、储藏和运输等加工过程中,往往会形成不匀晶核,不利于低温结晶过程中晶核的形成,因此在低温结晶前必须将不均匀晶核破坏。在30~50℃下加热处理5~30min能将鱼油完全融化从而破坏其中的不匀晶核。In the processing, storage and transportation of fish oil, uneven crystal nuclei are often formed, which is not conducive to the formation of crystal nuclei during low-temperature crystallization. Therefore, the uneven crystal nuclei must be destroyed before low-temperature crystallization. Heat treatment at 30~50℃ for 5~30min can completely melt the fish oil and destroy the uneven crystal nucleus.
作为优选,所述的有机溶剂为甲醇、无水乙醇、丙酮和正己烷中的一种或几种。Preferably, the organic solvent is one or more of methanol, absolute ethanol, acetone and n-hexane.
在低温结晶分离时,要求鱼油脂肪酸中的饱和酸和一烯酸、二烯酸等低不饱和度脂肪酸以晶体形式析出,而EPA与DHA仍留在溶液中,上述有机溶剂在较低温度时,仍对EPA和DHA有较好的溶解性,确保EPA和DHA尽量多地保留在溶液中。During low-temperature crystallization separation, saturated acid and monoenoic acid, dienoic acid and other low-unsaturated fatty acids in the fish oil fatty acid are required to be separated out in the form of crystals, while EPA and DHA remain in the solution, and the above-mentioned organic solvents are at a lower temperature. , still has good solubility for EPA and DHA, ensuring that EPA and DHA remain in the solution as much as possible.
作为优选,所述有机溶剂中含有质量百分比为0.8~1.2%的柠檬酸。Preferably, the organic solvent contains 0.8-1.2% by mass of citric acid.
少量柠檬酸的添加能促进在低温条件下EPA与DHA的快速结晶和晶粒的细化,提高结晶效率。The addition of a small amount of citric acid can promote the rapid crystallization and grain refinement of EPA and DHA at low temperature, and improve the crystallization efficiency.
作为优选,所述有机溶剂为体积比为(6~12):1的甲醇和无水乙醇的混合溶剂,所述有机溶剂中还含有质量百分比为0.9~1.1%的柠檬酸。Preferably, the organic solvent is a mixed solvent of methanol and absolute ethanol with a volume ratio of (6-12):1, and the organic solvent also contains 0.9-1.1% by mass of citric acid.
甲醇去除饱和脂肪酸的效果即对EPA和DHA的富集效果最好,无水乙醇次之,无水乙醇对低不饱和脂肪酸的去除效果较好,乙醇无毒,并具有价格便宜、挥发性小、闪点高等优点,但是黏度相对较大,结晶所需温度低。综合考虑,选择复配甲醇和无水乙醇作为低温结晶处理的溶剂。The effect of methanol in removing saturated fatty acids is that it has the best enrichment effect on EPA and DHA, followed by anhydrous ethanol, and anhydrous ethanol has a better removal effect on low-unsaturated fatty acids. , high flash point, but relatively high viscosity, low temperature required for crystallization. Comprehensive consideration, compound methanol and anhydrous ethanol are selected as solvents for low temperature crystallization.
作为优选,所述助晶剂为硅藻土、白土中的一种或两种。Preferably, the crystallizing agent is one or both of diatomite and white clay.
硅藻土、白土具有巨大的表面积,本发明在低温结晶过程中添加少量的硅藻土、白土,可以为鱼油中饱和脂肪酸成核提供较大的活化表面,降低成核自由能,使结晶体形成紧密有序的结构,加速后续晶体在其表面上生长。且硅藻土和白土在后续过程中通过离心处理即可除去,安全无毒。助晶剂添加量过少,生成的晶核数目少,结晶速率小,促进结晶的作用不明显;添加量过多,会因为过多异相杂质的存在影响饱和脂肪酸分子的运动,使得饱和脂肪酸分子向结晶前沿的扩散能力减弱,降低结晶速率。Diatomite and clay have a huge surface area. In the present invention, a small amount of diatomite and clay are added in the low-temperature crystallization process, which can provide a larger activation surface for the nucleation of saturated fatty acids in fish oil, reduce the nucleation free energy, and make crystals form. A tightly ordered structure that accelerates subsequent crystal growth on its surface. In addition, diatomite and white clay can be removed by centrifugation in the subsequent process, which is safe and non-toxic. If the addition amount of auxiliaries is too small, the number of crystal nuclei generated is small, the crystallization rate is small, and the effect of promoting crystallization is not obvious. The ability of molecules to diffuse to the crystallization front is weakened, reducing the crystallization rate.
作为优选,所述低温结晶在超声波搅拌中进行,所述超声波搅拌的超声功率300~500w,搅拌速率n=15~30r/minPreferably, the low-temperature crystallization is carried out in ultrasonic stirring, the ultrasonic power of the ultrasonic stirring is 300-500w, and the stirring rate is n=15-30r/min
用超声波处理过冷条件下的鱼油,会因超声波的絮凝作用形成大量晶核,超声波的空化作用又将形成的晶核击碎形成新的结晶中心,促进第二次成核,加速饱和脂肪酸结晶,缩短结晶诱导时间,改变晶体形态,使得结晶颗粒细小均匀,硬度增加。搅拌力度不够,会产生局部晶核,搅拌太剧烈,会使结晶撕碎,因此应控制适当的搅拌速度。结晶养晶过程中应保持持续慢速搅拌,有利于提高传热效率和结晶体的成长。Ultrasonic treatment of fish oil under supercooled conditions will form a large number of crystal nuclei due to the flocculation of ultrasonic waves, and the cavitation of ultrasonic waves will crush the formed crystal nuclei to form new crystallization centers, promote the second nucleation, and accelerate saturated fatty acids. Crystallization, shorten the crystallization induction time, change the crystal form, make the crystal particles fine and uniform, and increase the hardness. If the stirring strength is not enough, local crystal nuclei will be generated. If the stirring is too vigorous, the crystal will be torn apart, so the appropriate stirring speed should be controlled. Continuous slow stirring should be maintained during the crystallization and growth process, which is beneficial to improve the heat transfer efficiency and the growth of crystals.
作为优选,所述低温结晶包括第一阶段和第二阶段,第一阶段降温至-10~5℃,保温结晶3~4h,第二阶段降温至-30~-50℃,保温结晶2.5~3.5h。Preferably, the low-temperature crystallization includes a first stage and a second stage, the first stage is cooled to -10~5°C, the temperature is kept for 3~4 hours, the second stage is cooled to -30~-50°C, and the temperature is kept at a temperature of 2.5~3.5 h.
温度是脂肪酸结晶形成和分离的关键因素之一,温度太高,难以将热量从溶剂和鱼油与的混合物中传递环境中去,无法形成良好的过冷度,结晶核的形成受到限制,低温结晶后的未结晶液体中除了EPA、DHA外,仍含有大量其他组分,导致EPA、DHA比例降低。适当的结晶温度,有利于饱和脂肪酸形成结晶。但温度过低,会使EPA、DHA迁移至晶核,最终以结晶析出,降低EPA、DHA的富集率,且可能会导致形成的结晶较大而难以过滤,同时温度的降低会增加能耗,因此本发明将结晶温度控制在上述范围内。Temperature is one of the key factors for the formation and separation of fatty acid crystals. If the temperature is too high, it is difficult to transfer heat from the mixture of solvent and fish oil to the environment, so that a good degree of subcooling cannot be formed, and the formation of crystal nuclei is limited. In addition to EPA and DHA, the uncrystallized liquid still contains a large amount of other components, resulting in a decrease in the ratio of EPA and DHA. Appropriate crystallization temperature is conducive to the formation of crystallization of saturated fatty acids. However, if the temperature is too low, EPA and DHA will migrate to the crystal nucleus, and eventually precipitate as crystals, reducing the enrichment rate of EPA and DHA, and may cause the formed crystals to be larger and difficult to filter. At the same time, the decrease in temperature will increase energy consumption. , so the present invention controls the crystallization temperature within the above range.
结晶的过程分两步进行,晶核的生长和晶体增长,一旦形成晶核,晶体即开始增长。只要系统未达到饱和,温度未过冷,脂肪酸分子还具有较高流动性形成晶体,晶体将持续形成直到系统达到平衡。晶体的生长需要一定时间,因此结晶时间是一个很重要的因素。结晶时间不足,结晶不完全,一些饱和脂肪酸成分仍然存在于有机溶剂中,降低最终产品中EPA、DHA的比例;而结晶时间过长,可能导致部分EPA、DHA成分趋于结晶,导致EPA、DHA含量的降低。因此本发明将结晶时间控制在上述范围内。The process of crystallization is carried out in two steps, the growth of the nucleus and the growth of the crystal. Once the nucleus is formed, the crystal starts to grow. As long as the system is not saturated and the temperature is not supercooled, the fatty acid molecules also have high mobility to form crystals, which will continue to form until the system reaches equilibrium. The growth of crystals takes a certain amount of time, so the crystallization time is an important factor. Insufficient crystallization time, incomplete crystallization, and some saturated fatty acid components still exist in the organic solvent, reducing the proportion of EPA and DHA in the final product; while the crystallization time is too long, some EPA and DHA components may tend to crystallize, resulting in EPA and DHA. content reduction. Therefore, the present invention controls the crystallization time within the above-mentioned range.
本发明低温结晶的过程分两阶段进行,在结晶温度逐渐降低的过程中,降低到-10~5℃时,鱼油中饱和脂肪酸的结晶率增加迅速,温度再降低时,结晶率增速放缓,直到降低到-30~-50℃时,结晶率的增速再次加快,说明在-10~5℃和-30~-50℃时,鱼油中饱和脂肪酸结晶率较高。因此,本发明采用分段式结晶的方法,先在-10~5℃进行第一阶段的结晶,使此阶段内能够结晶的饱和脂肪酸充分结晶,再在-30~-50℃进行第二阶段的结晶,第一阶段的结晶降低了第二阶段结晶的压力,有助于能耗的降低,并且第一阶段的结晶可以作为第二阶段结晶的晶核,有助于第二阶段结晶的进行。The low-temperature crystallization process of the present invention is carried out in two stages. During the process of gradually decreasing the crystallization temperature, when the crystallization temperature is lowered to -10 to 5° C., the crystallization rate of saturated fatty acids in the fish oil increases rapidly, and when the temperature decreases again, the crystallization rate increases slowly. , until it decreased to -30~-50℃, the growth rate of crystallization rate accelerated again, indicating that the crystallization rate of saturated fatty acids in fish oil was higher at -10~5℃ and -30~-50℃. Therefore, the present invention adopts the method of segmental crystallization, firstly carries out the first stage of crystallization at -10 to 5°C, so that the saturated fatty acids that can be crystallized in this stage are fully crystallized, and then carries out the second stage at -30 to -50°C. The crystallization of the first stage reduces the pressure of the second stage crystallization, which helps to reduce the energy consumption, and the first stage crystallization can be used as the crystal nucleus of the second stage crystallization, which is conducive to the progress of the second stage crystallization. .
作为优选,所述第一阶段的降温速率为1~1.5℃/min,所述第二阶段的降温速率为1.3~1.8℃/min。Preferably, the cooling rate of the first stage is 1-1.5°C/min, and the cooling rate of the second stage is 1.3-1.8°C/min.
结晶体和为结晶液体的分离过程中,结晶体的晶型影响分离效果、最稳定晶型的获得由冷却速率和结晶温度决定。温差较大的急剧冷却易形成无法分离的玻璃质结晶体,采用合适的冷却速率缓慢冷却至结晶温度,才能获得相应的晶型。本发明在第一阶段采用较低的降温速率,有助于晶核的形成的晶体的初步生长,在第二阶段采用较快的降温速率有助于晶体的快速形成,从而提高结晶效率。During the separation process of crystal and crystalline liquid, the crystal form of crystal affects the separation effect, and the most stable crystal form is determined by cooling rate and crystallization temperature. Rapid cooling with a large temperature difference is likely to form inseparable glassy crystals, and the corresponding crystal form can be obtained by slowly cooling to the crystallization temperature with an appropriate cooling rate. The invention adopts a lower cooling rate in the first stage, which is helpful for the preliminary growth of the crystal formed by the crystal nucleus, and adopts a faster cooling rate in the second stage, which is conducive to the rapid formation of the crystal, thereby improving the crystallization efficiency.
与现有技术相比,本发明具有以下有益效果:本发明以乙酯型鱼油为原料,通过低温结晶法富集EPA、DHA,合理选择有机溶剂和助晶剂,并优化其工艺参数,分离富集得到高含量EPA、DHA的鱼油;操作简便,对仪器设备的要求低,单次处理量大,分离效果较好,且在低温环境下能够较好的保持EPA、DHA的天然活性,对鱼油的深加工利用和多不饱和脂肪酸系列保健品的开发有重要的参考意义。Compared with the prior art, the present invention has the following beneficial effects: the present invention takes the ethyl ester type fish oil as a raw material, enriches EPA and DHA by a low-temperature crystallization method, reasonably selects an organic solvent and a crystallizing agent, and optimizes its process parameters, and separates the The fish oil with high content of EPA and DHA can be obtained by enrichment; it is easy to operate, has low requirements for equipment, large single processing capacity, good separation effect, and can better maintain the natural activity of EPA and DHA under low temperature environment. The deep processing and utilization of fish oil and the development of polyunsaturated fatty acid series health care products have important reference significance.
具体实施方式Detailed ways
以下是本发明的具体实施例,对本发明的技术方案作进一步的描述,但本发明并不限于这些实施例。The following are specific embodiments of the present invention to further describe the technical solutions of the present invention, but the present invention is not limited to these embodiments.
下面通过具体实施例1~12对本发明中的富集鱼油EPA、DHA的方法作进一步解释。The method for enriching fish oil EPA and DHA in the present invention is further explained below through specific examples 1-12.
实施例1Example 1
本发明中低温结晶富集鱼油EPA、DHA的方法,包括如下步骤:The method for enriching fish oil EPA and DHA by low-temperature crystallization in the present invention comprises the steps:
将乙酯型鱼油在30℃下加热30min,乙酯化鱼油中的EPA、DHA质量百分比含量为50%;The ethyl ester type fish oil is heated at 30°C for 30min, and the mass percentage content of EPA and DHA in the ethyl ester fish oil is 50%;
在鱼油中加入甲醇和硅藻土,鱼油、甲醇和硅藻土的质量比为100:200:0.5,混匀形成混合物;Add methanol and diatomaceous earth to fish oil, the mass ratio of fish oil, methanol and diatomaceous earth is 100:200:0.5, and mix well to form a mixture;
将混合物放置低温设备中,在超声波搅拌的同时先以1.0℃/min的速率降温至5℃,保温结晶3h,再以1.3℃/min的速率降温至-30℃,保温结晶2.5h,超声功率300w,搅拌速率n=15r/min;The mixture was placed in a low-temperature equipment, and while ultrasonically stirred, it was first cooled to 5°C at a rate of 1.0°C/min, kept for crystallization for 3 hours, and then cooled to -30°C at a rate of 1.3°C/min, kept for 2.5 hours for crystallization, and the ultrasonic power 300w, stirring rate n=15r/min;
低温结晶后真空抽滤分离结晶体和未结晶液体,离心除去未结晶液体中的助晶剂,分子蒸馏除去未结晶液体中的有机溶剂,即得富集后的鱼油EPA、DHA。经检测,富集后的鱼油EPA、DHA中EPA和DHA的总含量为87.53%。After low-temperature crystallization, vacuum filtration separates crystals and uncrystallized liquid, centrifugally removes the crystallizer in the uncrystallized liquid, and molecular distillation removes the organic solvent in the uncrystallized liquid to obtain the enriched fish oil EPA and DHA. After testing, the total content of EPA and DHA in the enriched fish oil EPA and DHA was 87.53%.
实施例2Example 2
本发明中低温结晶富集鱼油EPA、DHA的方法,包括如下步骤:The method for enriching fish oil EPA and DHA by low-temperature crystallization in the present invention comprises the steps:
将乙酯型鱼油在35℃下加热25min,乙酯化鱼油中的EPA、DHA质量百分比含量为55%;The ethyl ester fish oil was heated at 35°C for 25 minutes, and the mass percentage content of EPA and DHA in the ethyl ester fish oil was 55%;
在鱼油中加入无水乙醇和白土,鱼油、无水乙醇和白土的质量比为100:400:1,混匀形成混合物;Add absolute ethanol and clay to the fish oil, the mass ratio of fish oil, absolute ethanol and clay is 100:400:1, and mix to form a mixture;
将混合物放置低温设备中,在超声波搅拌的同时先以1.3℃/min的速率降温至0℃,保温结晶3.5h,再以1.5℃/min的速率降温至-35℃,保温结晶3h,超声功率350w,搅拌速率n=20r/min;The mixture was placed in a low-temperature equipment, and while ultrasonically stirred, it was first cooled to 0°C at a rate of 1.3°C/min, kept for crystallization for 3.5 hours, and then cooled to -35°C at a rate of 1.5°C/min, kept for 3 hours for crystallization, and the ultrasonic power 350w, stirring speed n=20r/min;
低温结晶后真空抽滤分离结晶体和未结晶液体,离心除去未结晶液体中的助晶剂,分子蒸馏除去未结晶液体中的有机溶剂,即得富集后的鱼油EPA、DHA。经检测,富集后的鱼油EPA、DHA中EPA和DHA的总含量为87.62%。After low-temperature crystallization, vacuum filtration separates crystals and uncrystallized liquid, centrifugally removes the crystallizer in the uncrystallized liquid, and molecular distillation removes the organic solvent in the uncrystallized liquid to obtain the enriched fish oil EPA and DHA. After testing, the total content of EPA and DHA in the enriched fish oil EPA and DHA was 87.62%.
实施例3Example 3
本发明中低温结晶富集鱼油EPA、DHA的方法,包括如下步骤:The method for enriching fish oil EPA and DHA by low-temperature crystallization in the present invention comprises the steps:
将乙酯型鱼油在40℃下加热20min,乙酯化鱼油中的EPA、DHA质量百分比含量为60%;The ethyl ester type fish oil was heated at 40°C for 20min, and the mass percentage content of EPA and DHA in the ethyl ester fish oil was 60%;
在鱼油中加入丙酮和硅藻土,鱼油、丙酮和硅藻土的质量比为100:600:1.5,混匀形成混合物;Add acetone and diatomaceous earth to fish oil, the mass ratio of fish oil, acetone and diatomaceous earth is 100:600:1.5, and mix to form a mixture;
将混合物放置低温设备中,在超声波搅拌的同时先以1.5℃/min的速率降温至-3℃,保温结晶4h,再以1.8℃/min的速率降温至-40℃,保温结晶3.5h,超声功率400w,搅拌速率n=25r/min;The mixture was placed in a low-temperature equipment, and while ultrasonically stirred, it was first cooled to -3 °C at a rate of 1.5 °C/min, kept for crystallization for 4 hours, and then cooled to -40 °C at a rate of 1.8 °C/min, kept for 3.5 hours for crystallization, and ultrasonicated. Power 400w, stirring speed n=25r/min;
低温结晶后真空抽滤分离结晶体和未结晶液体,离心除去未结晶液体中的助晶剂,分子蒸馏除去未结晶液体中的有机溶剂,即得富集后的鱼油EPA、DHA。经检测,富集后的鱼油EPA、DHA中EPA和DHA的总含量为88.87%。After low-temperature crystallization, vacuum filtration separates crystals and uncrystallized liquid, centrifugally removes the crystallizer in the uncrystallized liquid, and molecular distillation removes the organic solvent in the uncrystallized liquid to obtain the enriched fish oil EPA and DHA. After testing, the total content of EPA and DHA in the enriched fish oil EPA and DHA was 88.87%.
实施例4Example 4
本发明中低温结晶富集鱼油EPA、DHA的方法,包括如下步骤:The method for enriching fish oil EPA and DHA by low-temperature crystallization in the present invention comprises the steps:
将乙酯型鱼油在40℃下加热10min,乙酯化鱼油中的EPA、DHA质量百分比含量为70%;The ethyl ester fish oil was heated at 40°C for 10 min, and the mass percentage content of EPA and DHA in the ethyl ester fish oil was 70%;
在鱼油中加入正己烷和白土,鱼油、正己烷和白土的质量比为100:800:2,混匀形成混合物;Add n-hexane and clay to fish oil, the mass ratio of fish oil, n-hexane and clay is 100:800:2, and mix to form a mixture;
将混合物放置低温设备中,在超声波搅拌的同时先以1.4℃/min的速率降温至-5℃,保温结晶3.5h,再以1.7℃/min的速率降温至-45℃,保温结晶3h,超声功率450w,搅拌速率n=30r/min;The mixture was placed in a low-temperature equipment, and while ultrasonically stirred, it was first cooled to -5°C at a rate of 1.4°C/min, kept for crystallization for 3.5 hours, and then cooled to -45°C at a rate of 1.7°C/min, kept for 3 hours for crystallization, and ultrasonicated. Power 450w, stirring speed n=30r/min;
低温结晶后真空抽滤分离结晶体和未结晶液体,离心除去未结晶液体中的助晶剂,分子蒸馏除去未结晶液体中的有机溶剂,即得富集后的鱼油EPA、DHA。经检测,富集后的鱼油EPA、DHA中EPA和DHA的总含量为89.71%。After low-temperature crystallization, vacuum filtration separates crystals and uncrystallized liquid, centrifugally removes the crystallizer in the uncrystallized liquid, and molecular distillation removes the organic solvent in the uncrystallized liquid to obtain the enriched fish oil EPA and DHA. After testing, the total content of EPA and DHA in the enriched fish oil EPA and DHA was 89.71%.
实施例5Example 5
本发明中低温结晶富集鱼油EPA、DHA的方法,包括如下步骤:The method for enriching fish oil EPA and DHA by low-temperature crystallization in the present invention comprises the steps:
将乙酯型鱼油在50℃下加热5min,乙酯化鱼油中的EPA、DHA质量百分比含量为65%;The ethyl ester fish oil was heated at 50°C for 5 min, and the mass percentage content of EPA and DHA in the ethyl ester fish oil was 65%;
在鱼油中加入有机溶剂和硅藻土,鱼油、有机溶剂和硅藻土的质量比为100:1000:2,混匀形成混合物,有机溶剂为体积比为6:1的甲醇和无水乙醇的混合溶剂;Add organic solvent and diatomaceous earth to fish oil, the mass ratio of fish oil, organic solvent and diatomaceous earth is 100:1000:2, mix well to form a mixture, the organic solvent is methanol and absolute ethanol with a volume ratio of 6:1 mixed solvent;
将混合物放置低温设备中,在超声波搅拌的同时先以1.3℃/min的速率降温至-10℃,保温结晶3.5h,再以1.6℃/min的速率降温至-50℃,保温结晶3h,超声功率500w,搅拌速率n=25r/min;The mixture was placed in a low-temperature equipment, and while ultrasonically stirred, it was first cooled to -10°C at a rate of 1.3°C/min, kept for 3.5 hours for crystallization, and then cooled to -50°C at a rate of 1.6°C/min, kept for 3 hours for crystallization, and ultrasonicated. Power 500w, stirring speed n=25r/min;
低温结晶后真空抽滤分离结晶体和未结晶液体,离心除去未结晶液体中的助晶剂,分子蒸馏除去未结晶液体中的有机溶剂,即得富集后的鱼油EPA、DHA。经检测,富集后的鱼油EPA、DHA中EPA和DHA的总含量为89.63%。After low-temperature crystallization, vacuum filtration separates crystals and uncrystallized liquid, centrifugally removes the crystallizer in the uncrystallized liquid, and molecular distillation removes the organic solvent in the uncrystallized liquid to obtain the enriched fish oil EPA and DHA. After testing, the total content of EPA and DHA in the enriched fish oil EPA and DHA was 89.63%.
实施例6Example 6
本发明中低温结晶富集鱼油EPA、DHA的方法,包括如下步骤:The method for enriching fish oil EPA and DHA by low-temperature crystallization in the present invention comprises the steps:
将乙酯型鱼油在40℃下加热20min,乙酯化鱼油中的EPA、DHA质量百分比含量为60%;The ethyl ester type fish oil was heated at 40°C for 20min, and the mass percentage content of EPA and DHA in the ethyl ester fish oil was 60%;
在鱼油中加入有机溶剂和助晶剂,鱼油、有机溶剂和助晶剂的质量比为100:600:1.5,混匀形成混合物,有机溶剂为体积比为9:1的甲醇和无水乙醇的混合溶剂,助晶剂为质量比为2:1的硅藻土和白土的混合物;Add organic solvent and crystallizer to fish oil, the mass ratio of fish oil, organic solvent and crystallizer is 100:600:1.5, mix well to form a mixture, and the organic solvent is methanol and absolute ethanol with a volume ratio of 9:1 Mixed solvent, the crystallization aid is a mixture of diatomite and white clay with a mass ratio of 2:1;
将混合物放置低温设备中,在超声波搅拌的同时先以1.3℃/min的速率降温至-10℃,保温结晶3.5h,再以1.7℃/min的速率降温至-50℃,保温结晶3h,超声功率400w,搅拌速率n=20r/min;The mixture was placed in a low-temperature equipment, and while ultrasonically stirred, it was first cooled to -10°C at a rate of 1.3°C/min, kept for 3.5 hours for crystallization, and then cooled to -50°C at a rate of 1.7°C/min, kept for 3 hours for crystallization, and ultrasonicated. Power 400w, stirring speed n=20r/min;
低温结晶后真空抽滤分离结晶体和未结晶液体,离心除去未结晶液体中的助晶剂,分子蒸馏除去未结晶液体中的有机溶剂,即得富集后的鱼油EPA、DHA。经检测,富集后的鱼油EPA、DHA中EPA和DHA的总含量为89.20%。After low-temperature crystallization, vacuum filtration separates crystals and uncrystallized liquid, centrifugally removes the crystallizer in the uncrystallized liquid, and molecular distillation removes the organic solvent in the uncrystallized liquid to obtain the enriched fish oil EPA and DHA. After testing, the total content of EPA and DHA in the enriched fish oil EPA and DHA was 89.20%.
实施例7Example 7
本发明中低温结晶富集鱼油EPA、DHA的方法,包括如下步骤:The method for enriching fish oil EPA and DHA by low-temperature crystallization in the present invention comprises the steps:
将乙酯型鱼油在40℃下加热20min,乙酯化鱼油中的EPA、DHA质量百分比含量为60%;The ethyl ester type fish oil was heated at 40°C for 20min, and the mass percentage content of EPA and DHA in the ethyl ester fish oil was 60%;
在鱼油中加入有机溶剂和助晶剂,鱼油、有机溶剂和助晶剂的质量比为100:600:1.5,混匀形成混合物,有机溶剂为体积比为12:1的甲醇和无水乙醇的混合溶剂,助晶剂为质量比为1:1的硅藻土和白土的混合物;Add organic solvent and crystallizer to fish oil, the mass ratio of fish oil, organic solvent and crystallizer is 100:600:1.5, mix well to form a mixture, and the organic solvent is methanol and absolute ethanol with a volume ratio of 12:1 Mixed solvent, the crystallization aid is a mixture of diatomite and white clay with a mass ratio of 1:1;
将混合物放置低温设备中,在超声波搅拌的同时先以1.2℃/min的速率降温至-10℃,保温结晶3.5h,再以1.6℃/min的速率降温至-50℃,保温结晶3h,超声功率400w,搅拌速率n=20r/min;The mixture was placed in a low-temperature equipment, and while ultrasonically stirred, it was first cooled to -10 °C at a rate of 1.2 °C/min, kept for 3.5 hours for crystallization, and then cooled to -50 °C at a rate of 1.6 °C/min, kept for 3 hours for crystallization, and ultrasonicated. Power 400w, stirring speed n=20r/min;
低温结晶后真空抽滤分离结晶体和未结晶液体,离心除去未结晶液体中的助晶剂,分子蒸馏除去未结晶液体中的有机溶剂,即得富集后的鱼油EPA、DHA。经检测,富集后的鱼油EPA、DHA中EPA和DHA的总含量为89.21%。After low-temperature crystallization, vacuum filtration separates crystals and uncrystallized liquid, centrifugally removes the crystallizer in the uncrystallized liquid, and molecular distillation removes the organic solvent in the uncrystallized liquid to obtain the enriched fish oil EPA and DHA. After testing, the total content of EPA and DHA in the enriched fish oil EPA and DHA was 89.21%.
实施例8Example 8
本发明中低温结晶富集鱼油EPA、DHA的方法,包括如下步骤,乙酯化鱼油中的EPA、DHA质量百分比含量为60%:The method for enriching fish oil EPA and DHA by low-temperature crystallization in the present invention comprises the following steps, and the mass percentage content of EPA and DHA in the ethyl esterified fish oil is 60%:
将乙酯型鱼油在40℃下加热20min;The ethyl ester fish oil was heated at 40°C for 20min;
在鱼油中加入有机溶剂和助晶剂,鱼油、有机溶剂和助晶剂的质量比为100:600:1.5,混匀形成混合物,有机溶剂为体积比为9:1的甲醇和无水乙醇的混合溶剂,有机溶剂中含有质量百分比为0.8%的柠檬酸,助晶剂为质量比为2:1的硅藻土和白土的混合物;Add organic solvent and crystallizer to fish oil, the mass ratio of fish oil, organic solvent and crystallizer is 100:600:1.5, mix well to form a mixture, and the organic solvent is methanol and absolute ethanol with a volume ratio of 9:1 Mixed solvent, the organic solvent contains citric acid with a mass percentage of 0.8%, and the crystallizing agent is a mixture of diatomite and white clay with a mass ratio of 2:1;
将混合物放置低温设备中,在超声波搅拌的同时先以1.2℃/min的速率降温至-10℃,保温结晶3.5h,再以1.6℃/min的速率降温至-50℃,保温结晶3h,超声功率400w,搅拌速率n=20r/min;The mixture was placed in a low-temperature equipment, and while ultrasonically stirred, it was first cooled to -10 °C at a rate of 1.2 °C/min, kept for 3.5 hours for crystallization, and then cooled to -50 °C at a rate of 1.6 °C/min, kept for 3 hours for crystallization, and ultrasonicated. Power 400w, stirring speed n=20r/min;
低温结晶后真空抽滤分离结晶体和未结晶液体,离心除去未结晶液体中的助晶剂,分子蒸馏除去未结晶液体中的有机溶剂,即得富集后的鱼油EPA、DHA。经检测,富集后的鱼油EPA、DHA中EPA和DHA的总含量为90.02%。After low-temperature crystallization, vacuum filtration separates crystals and uncrystallized liquid, centrifugally removes the crystallizer in the uncrystallized liquid, and molecular distillation removes the organic solvent in the uncrystallized liquid to obtain the enriched fish oil EPA and DHA. After testing, the total content of EPA and DHA in the enriched fish oil EPA and DHA was 90.02%.
实施例9Example 9
本发明中低温结晶富集鱼油EPA、DHA的方法,包括如下步骤,乙酯化鱼油中的EPA、DHA质量百分比含量为60%:The method for enriching fish oil EPA and DHA by low-temperature crystallization in the present invention comprises the following steps, and the mass percentage content of EPA and DHA in the ethyl esterified fish oil is 60%:
将乙酯型鱼油在40℃下加热20min;The ethyl ester fish oil was heated at 40°C for 20min;
在鱼油中加入有机溶剂和助晶剂,鱼油、有机溶剂和助晶剂的质量比为100:600:1.5,混匀形成混合物,有机溶剂为体积比为9:1的甲醇和无水乙醇的混合溶剂,有机溶剂中含有质量百分比为0.9%的柠檬酸,助晶剂为质量比为2:1的硅藻土和白土的混合物;Add organic solvent and crystallizer to fish oil, the mass ratio of fish oil, organic solvent and crystallizer is 100:600:1.5, mix well to form a mixture, and the organic solvent is methanol and absolute ethanol with a volume ratio of 9:1 Mixed solvent, the organic solvent contains citric acid with a mass percentage of 0.9%, and the crystallizing agent is a mixture of diatomite and white clay with a mass ratio of 2:1;
将混合物放置低温设备中,在超声波搅拌的同时先以1.3℃/min的速率降温至-10℃,保温结晶3.5h,再以1.8℃/min的速率降温至-50℃,保温结晶3h,超声功率400w,搅拌速率n=20r/min;The mixture was placed in a low-temperature equipment, and while ultrasonically stirred, it was first cooled to -10 °C at a rate of 1.3 °C/min, kept for crystallization for 3.5 hours, and then cooled to -50 °C at a rate of 1.8 °C/min, kept for 3 hours for crystallization, and ultrasonicated. Power 400w, stirring speed n=20r/min;
低温结晶后真空抽滤分离结晶体和未结晶液体,离心除去未结晶液体中的助晶剂,分子蒸馏除去未结晶液体中的有机溶剂,即得富集后的鱼油EPA、DHA。经检测,富集后的鱼油EPA、DHA中EPA和DHA的总含量为90.11%。After low-temperature crystallization, vacuum filtration separates crystals and uncrystallized liquid, centrifugally removes the crystallizer in the uncrystallized liquid, and molecular distillation removes the organic solvent in the uncrystallized liquid to obtain the enriched fish oil EPA and DHA. After testing, the total content of EPA and DHA in the enriched fish oil EPA and DHA was 90.11%.
实施例10Example 10
本发明中低温结晶富集鱼油EPA、DHA的方法,包括如下步骤,乙酯化鱼油中的EPA、DHA质量百分比含量为60%:The method for enriching fish oil EPA and DHA by low-temperature crystallization in the present invention comprises the following steps, and the mass percentage content of EPA and DHA in the ethyl esterified fish oil is 60%:
将乙酯型鱼油在40℃下加热20min;The ethyl ester fish oil was heated at 40°C for 20min;
在鱼油中加入有机溶剂和助晶剂,鱼油、有机溶剂和助晶剂的质量比为100:600:1.5,混匀形成混合物,有机溶剂为体积比为9:1的甲醇和无水乙醇的混合溶剂,有机溶剂中含有质量百分比为1.0%的柠檬酸,助晶剂为质量比为2:1的硅藻土和白土的混合物;Add organic solvent and crystallizer to fish oil, the mass ratio of fish oil, organic solvent and crystallizer is 100:600:1.5, mix well to form a mixture, and the organic solvent is methanol and absolute ethanol with a volume ratio of 9:1 Mixed solvent, the organic solvent contains citric acid with a mass percentage of 1.0%, and the crystallizing agent is a mixture of diatomite and white clay with a mass ratio of 2:1;
将混合物放置低温设备中,在超声波搅拌的同时先以1.1℃/min的速率降温至-10℃,保温结晶3.5h,再以1.6℃/min的速率降温至-50℃,保温结晶3h,超声功率400w,搅拌速率n=20r/min;The mixture was placed in a low-temperature equipment, and while ultrasonically stirred, it was first cooled to -10°C at a rate of 1.1°C/min, kept for 3.5 hours for crystallization, and then cooled to -50°C at a rate of 1.6°C/min, kept for 3 hours for crystallization, and ultrasonicated. Power 400w, stirring speed n=20r/min;
低温结晶后真空抽滤分离结晶体和未结晶液体,离心除去未结晶液体中的助晶剂,分子蒸馏除去未结晶液体中的有机溶剂,即得富集后的鱼油EPA、DHA。经检测,富集后的鱼油EPA、DHA中EPA和DHA的总含量为92.00%。After low-temperature crystallization, vacuum filtration separates crystals and uncrystallized liquid, centrifugally removes the crystallizer in the uncrystallized liquid, and molecular distillation removes the organic solvent in the uncrystallized liquid to obtain the enriched fish oil EPA and DHA. After testing, the total content of EPA and DHA in the enriched fish oil EPA and DHA was 92.00%.
实施例11Example 11
本发明中低温结晶富集鱼油EPA、DHA的方法,包括如下步骤,乙酯化鱼油中的EPA、DHA质量百分比含量为60%:The method for enriching fish oil EPA and DHA by low-temperature crystallization in the present invention comprises the following steps, and the mass percentage content of EPA and DHA in the ethyl esterified fish oil is 60%:
将乙酯型鱼油在40℃下加热20min;The ethyl ester fish oil was heated at 40°C for 20min;
在鱼油中加入有机溶剂和助晶剂,鱼油、有机溶剂和助晶剂的质量比为100:600:1.5,混匀形成混合物,有机溶剂为体积比为9:1的甲醇和无水乙醇的混合溶剂,有机溶剂中含有质量百分比为1.1%的柠檬酸,助晶剂为质量比为2:1的硅藻土和白土的混合物;Add organic solvent and crystallizer to fish oil, the mass ratio of fish oil, organic solvent and crystallizer is 100:600:1.5, mix well to form a mixture, and the organic solvent is methanol and absolute ethanol with a volume ratio of 9:1 Mixed solvent, the organic solvent contains citric acid with a mass percentage of 1.1%, and the crystallizing agent is a mixture of diatomite and white clay with a mass ratio of 2:1;
将混合物放置低温设备中,在超声波搅拌的同时先以1.3℃/min的速率降温至-10℃,保温结晶3.5h,再以1.7℃/min的速率降温至-50℃,保温结晶3h,超声功率400w,搅拌速率n=20r/min;The mixture was placed in a low-temperature equipment, and while ultrasonically stirred, it was first cooled to -10°C at a rate of 1.3°C/min, kept for 3.5 hours for crystallization, and then cooled to -50°C at a rate of 1.7°C/min, kept for 3 hours for crystallization, and ultrasonicated. Power 400w, stirring speed n=20r/min;
低温结晶后真空抽滤分离结晶体和未结晶液体,离心除去未结晶液体中的助晶剂,分子蒸馏除去未结晶液体中的有机溶剂,即得富集后的鱼油EPA、DHA。经检测,富集后的鱼油EPA、DHA中EPA和DHA的总含量为91.65%。After low-temperature crystallization, vacuum filtration to separate the crystal and the uncrystallized liquid, centrifugally remove the crystallizer in the uncrystallized liquid, and molecular distillation to remove the organic solvent in the uncrystallized liquid to obtain the enriched fish oil EPA and DHA. After testing, the total content of EPA and DHA in the enriched fish oil EPA and DHA was 91.65%.
实施例12Example 12
本发明中低温结晶富集鱼油EPA、DHA的方法,包括如下步骤,乙酯化鱼油中的EPA、DHA质量百分比含量为60%:The method for enriching fish oil EPA and DHA by low-temperature crystallization in the present invention comprises the following steps, and the mass percentage content of EPA and DHA in the ethyl esterified fish oil is 60%:
将乙酯型鱼油在40℃下加热20min;The ethyl ester fish oil was heated at 40°C for 20min;
在鱼油中加入有机溶剂和助晶剂,鱼油、有机溶剂和助晶剂的质量比为100:600:1.5,混匀形成混合物,有机溶剂为体积比为9:1的甲醇和无水乙醇的混合溶剂,有机溶剂中含有质量百分比为1.2%的柠檬酸,助晶剂为质量比为2:1的硅藻土和白土的混合物;Add organic solvent and crystallizer to fish oil, the mass ratio of fish oil, organic solvent and crystallizer is 100:600:1.5, mix well to form a mixture, and the organic solvent is methanol and absolute ethanol with a volume ratio of 9:1 Mixed solvent, the organic solvent contains citric acid with a mass percentage of 1.2%, and the crystallizing agent is a mixture of diatomite and white clay with a mass ratio of 2:1;
将混合物放置低温设备中,在超声波搅拌的同时先以1.2℃/min的速率降温至-10℃,保温结晶3.5h,再以1.5℃/min的速率降温至-50℃,保温结晶3h,超声功率400w,搅拌速率n=20r/min;The mixture was placed in a low-temperature equipment, and while ultrasonically stirred, it was first cooled to -10°C at a rate of 1.2°C/min, kept for 3.5 hours for crystallization, and then cooled to -50°C at a rate of 1.5°C/min, kept for 3 hours for crystallization, and ultrasonicated. Power 400w, stirring speed n=20r/min;
低温结晶后真空抽滤分离结晶体和未结晶液体,离心除去未结晶液体中的助晶剂,分子蒸馏除去未结晶液体中的有机溶剂,即得富集后的鱼油EPA、DHA。经检测,富集后的鱼油EPA、DHA中EPA和DHA的总含量为91.86%。After low-temperature crystallization, vacuum filtration separates crystals and uncrystallized liquid, centrifugally removes the crystallizer in the uncrystallized liquid, and molecular distillation removes the organic solvent in the uncrystallized liquid to obtain the enriched fish oil EPA and DHA. After testing, the total content of EPA and DHA in the enriched fish oil EPA and DHA was 91.86%.
对比例1Comparative Example 1
富集过程中未添加助晶剂,其他与实施例10相同。经检测,富集后的鱼油EPA、DHA中EPA和DHA的总含量为83.16%。No crystallizing agent was added during the enrichment process, and the others were the same as in Example 10. After testing, the total content of EPA and DHA in the enriched fish oil EPA and DHA was 83.16%.
对比例2Comparative Example 2
低温冷冻过程中,在超声波搅拌的同时以18℃/min的速率降温至-30℃,保温结晶5.5h,其他与实施例10相同。经检测,富集后的鱼油EPA、DHA中EPA和DHA的总含量为83.93%。During the low-temperature freezing process, the temperature was lowered to -30°C at a rate of 18°C/min while ultrasonic stirring, and the temperature was kept for 5.5h for crystallization. After testing, the total content of EPA and DHA in the enriched fish oil EPA and DHA was 83.93%.
对比例3Comparative Example 3
低温冷冻过程中,未使用超声波,其他与实施例10相同。经检测,富集后的鱼油EPA、DHA中EPA和DHA的总含量为86.19%。During the low-temperature freezing process, ultrasonic waves were not used, and others were the same as in Example 10. After testing, the total content of EPA and DHA in the enriched fish oil EPA and DHA was 86.19%.
综上所述,本发明以乙酯型鱼油为原料,通过低温结晶法富集EPA、DHA,在富集的过程中,合理优化其工艺参数;添加有硅藻土和白土作为助晶剂,增加异相成核的比例,降低过冷度,提高结晶温度;并辅以超声波搅拌,增加结晶效率;结晶过程中采用两段式结晶方法,降低结晶能耗,增加结晶效率;该方法操作简便,对仪器设备的要求低,单次处理量大,分离效果较好,且在低温环境下能够较好的保持EPA、DHA的天然活性。To sum up, the present invention uses ethyl ester type fish oil as raw material, enriches EPA and DHA by low-temperature crystallization method, and rationally optimizes its technological parameters during the enrichment process; Increase the proportion of heterogeneous nucleation, reduce the degree of undercooling, and increase the crystallization temperature; and supplemented by ultrasonic stirring to increase the crystallization efficiency; the two-stage crystallization method is used in the crystallization process to reduce the energy consumption of crystallization and increase the crystallization efficiency; this method is easy to operate , The requirements for instruments and equipment are low, the single treatment capacity is large, the separation effect is good, and the natural activity of EPA and DHA can be better maintained in a low temperature environment.
本文中所描述的具体实施例仅仅是对本发明精神作举例说明。本发明所属技术领域的技术人员可以对所描述的具体实施例做各种各样的修改或补充或采用类似的方式替代,但并不会偏离本发明的精神或者超越所附权利要求书所定义的范围。The specific embodiments described herein are merely illustrative of the spirit of the invention. Those skilled in the art to which the present invention pertains can make various modifications or additions to the described specific embodiments or substitute in similar manners, but will not deviate from the spirit of the present invention or go beyond the definitions of the appended claims range.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710747330.0A CN107629873B (en) | 2017-08-28 | 2017-08-28 | A kind of method of low-temperature crystallization enriching fish oil EPA, DHA |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710747330.0A CN107629873B (en) | 2017-08-28 | 2017-08-28 | A kind of method of low-temperature crystallization enriching fish oil EPA, DHA |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107629873A CN107629873A (en) | 2018-01-26 |
CN107629873B true CN107629873B (en) | 2020-08-25 |
Family
ID=61101677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710747330.0A Active CN107629873B (en) | 2017-08-28 | 2017-08-28 | A kind of method of low-temperature crystallization enriching fish oil EPA, DHA |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107629873B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110668945B (en) * | 2019-09-29 | 2022-02-15 | 青岛利和生物科技有限公司 | Method for extracting DHA and EPA in fish oil by combining supercritical fluid |
CN117229846A (en) * | 2022-06-08 | 2023-12-15 | 浙江可明生物医药有限公司 | Method for efficiently separating solid fat from polyunsaturated fatty acid fat |
CN115715559B (en) * | 2022-11-08 | 2024-09-10 | 嘉必优生物技术(武汉)股份有限公司 | Method for enriching DHA in grease |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1478875A (en) * | 2003-07-21 | 2004-03-03 | 天津市医药科学研究所 | Method of purifying high content DHA, EPA from fish oil |
CN104402697A (en) * | 2014-10-11 | 2015-03-11 | 天津大学 | A kind of ultrasonic-assisted coenzyme Q10 crystallization method |
CN105218367A (en) * | 2014-06-09 | 2016-01-06 | 四川国为制药有限公司 | A kind of High Purity Ethyl Eicosapentaenoate enriched material |
JP2017082095A (en) * | 2015-10-28 | 2017-05-18 | 花王株式会社 | Method for producing fractionated fish oil |
-
2017
- 2017-08-28 CN CN201710747330.0A patent/CN107629873B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1478875A (en) * | 2003-07-21 | 2004-03-03 | 天津市医药科学研究所 | Method of purifying high content DHA, EPA from fish oil |
CN105218367A (en) * | 2014-06-09 | 2016-01-06 | 四川国为制药有限公司 | A kind of High Purity Ethyl Eicosapentaenoate enriched material |
CN104402697A (en) * | 2014-10-11 | 2015-03-11 | 天津大学 | A kind of ultrasonic-assisted coenzyme Q10 crystallization method |
JP2017082095A (en) * | 2015-10-28 | 2017-05-18 | 花王株式会社 | Method for producing fractionated fish oil |
Non-Patent Citations (1)
Title |
---|
"低温结晶富集鱼油中EPA与DHA的方法;李和等;《中国海洋药物》;19971201(第4期);第50-52页 * |
Also Published As
Publication number | Publication date |
---|---|
CN107629873A (en) | 2018-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107629873B (en) | A kind of method of low-temperature crystallization enriching fish oil EPA, DHA | |
CN102388988B (en) | Separated extraction method of microorganism oil | |
CN102229866B (en) | Method for producing 1,3-dioleoyl-2-palmitoyl triglyceride | |
CN102229860A (en) | Supersonic wave method for promoting rapid crystallization and fractionation of palm oil | |
CN115974651B (en) | Method for preparing medical propylene glycol from propylene glycol prepared by transesterification method | |
CN101664214A (en) | Ultrasonic synergetic crystal growing fruit juice freezing and concentrating method and equipment thereof | |
CN108017535A (en) | A kind of method that long-chain biatomic acid is extracted from zymotic fluid | |
CN105753689B (en) | Method for extracting and purifying α -linolenic acid from linseed oil | |
WO2020024643A1 (en) | Method for winterizing microbial oil | |
CN1257142C (en) | Preparation for active octacosa alkanol and triaconta alkanol in rice bran | |
CN102676294A (en) | Dewaxing method of rice oil | |
WO2016058282A1 (en) | Method for recycling urea in urea adduct process | |
CN107602386B (en) | A kind of method of low temperature crystallization enrichment ethyl esterification fish oil EPA, DHA | |
CN102321500A (en) | Efficient method for producing high-quality antifreeze tea oil | |
CN1736970A (en) | Xylitol refined crystallization method | |
CN104437115A (en) | Composite filtering membrane for aquatic product aquaculture water, and preparation method of composite filtering membrane | |
CN108929786B (en) | A kind of enrichment method of branched chain fatty acid | |
CN109528784B (en) | A kind of method for extracting and preparing 4,4'-dimethyl sterol from shea butter | |
CN105602720A (en) | Method for fractionating mango kernel fat by virtue of solvent | |
CN106554273B (en) | Method for purifying long-chain dicarboxylic acid in fermentation liquor | |
CN110606863B (en) | A kind of preparation method of N-acetylneuraminic acid dihydrate | |
JP6692232B2 (en) | 3HB manufacturing method | |
CN116076583B (en) | Preparation method of liquid seasoning mutton fat with low cholesterol and low mutton smell | |
CN113943605B (en) | Winterization and fractionation method for microbial oil | |
JPS6361290B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230411 Address after: 610000 room 615, 6 / F, building 1, No. 57-59 Baisi street, Qingyang District, Chengdu, Sichuan Patentee after: Chengdu weizhimao Enterprise Management Co.,Ltd. Address before: 316022 No.1 Haida South Road, Changzhi Island, Lincheng street, Dinghai District, Zhoushan City, Zhejiang Province Patentee before: Zhejiang Ocean University Effective date of registration: 20230411 Address after: 266000 room 306, T6 / F, Shangshi center, 195 Hong Kong East Road, Laoshan District, Qingdao City, Shandong Province Patentee after: Fengshi (Qingdao) Ocean Technology Co.,Ltd. Address before: 610000 room 615, 6 / F, building 1, No. 57-59 Baisi street, Qingyang District, Chengdu, Sichuan Patentee before: Chengdu weizhimao Enterprise Management Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: 266000 room 306, T6 / F, Shangshi center, 195 Hong Kong East Road, Laoshan District, Qingdao City, Shandong Province Patentee after: Fengshi (Qingdao) Marine Technology Co.,Ltd. Country or region after: China Address before: 266000 room 306, T6 / F, Shangshi center, 195 Hong Kong East Road, Laoshan District, Qingdao City, Shandong Province Patentee before: Fengshi (Qingdao) Ocean Technology Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |